SARS-CoV-2

A team of researchers at the Näär Lab at UC Berkeley have developed a new inhalable drug that blocks the viral replication of SARS-CoV-2 in lung cells.

Researchers at UC Berkeley, the Gladstone Institutes and Innovative Genomics Institute discovered that the antibodies generated against SARS-CoV-2 and its variants are less effective against omicron.

On Saturday, Western States Scientific Safety Review Workgroup expanded eligibility for the COVID-19 booster shot to all adults older than 18, easing complications of eligibility and increasing distribution of the vaccine. 

Researchers from UC Berkeley and Gladstone Institutes identified why some variants of SARS-CoV-2, the virus that causes COVID-19, lead to increased transmission and infectivity in a study published Nov. 4.

Scientists from UC Berkeley are part of a research team using Nobel Prize-winning CRISPR technology to develop a COVID-19 diagnostic test that is fast, convenient and can be performed on site.

A team of researchers discovered that molecules called peptoids, which they synthesized at the Lawrence Berkeley National Lab, or the Berkeley Lab, can be used to fight a variety of viruses.

As the Delta variant of the SARS-CoV-2 virus continues to spread rapidly across the country, Berkeley and multiple counties recommended that people continue to wear masks indoors.

UC Berkeley researchers helped publish a study June 22 looking into the structure of a new protein expressed by the SARS-CoV-2 ORF3a gene, the discovery possibly leading to further strides against COVID-19.

Inklings of COVID-19 vaccination requirements for returning UC Berkeley students emerged Thursday as the UC system proposed a policy mandating the vaccine.

As part of efforts to track levels of the SARS-CoV-2 virus, which causes COVID-19, UC Berkeley announced its wastewater testing dashboard Wednesday, which monitors levels of the virus in sewage.